Literature DB >> 32154808

High-resolution human leukocyte antigen typing and early post-transplant outcomes: more than meets the eye.

Annelore Sacreas1, Stijn E Verleden1.   

Abstract

Entities:  

Year:  2020        PMID： 32154808      PMCID： PMC7036625          DOI： 10.21037/atm.2020.01.110

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Impact of human leukocyte antigen mismatch on lung transplant outcome.

Authors:  Yoshito Yamada; Tim Langner; Ilhan Inci; Christian Benden; Macé Schuurmans; Walter Weder; Wolfgang Jungraithmayr
Journal:  Interact Cardiovasc Thorac Surg       Date:  2018-05-01

Review 2.  Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.

Authors:  Joshua M Diamond; Selim Arcasoy; Cassie C Kennedy; Michael Eberlein; Jonathan P Singer; Glenda M Patterson; Jeffrey D Edelman; Gundeep Dhillon; Tahuanty Pena; Steven M Kawut; James C Lee; Reda Girgis; John Dark; Gabriel Thabut
Journal:  J Heart Lung Transplant       Date:  2017-07-26       Impact factor: 10.247

Review 3.  Antibody-Mediated Rejection of Solid-Organ Allografts.

Authors:  Alexandre Loupy; Carmen Lefaucheur
Journal:  N Engl J Med       Date:  2018-09-20       Impact factor: 91.245

Review 4.  Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.

Authors:  Jennifer A McCaughan; Kathryn J Tinckam
Journal:  Transpl Int       Date:  2018-10       Impact factor: 3.782

5.  The effect of primary graft dysfunction on survival after lung transplantation.

Authors:  Jason D Christie; Robert M Kotloff; Vivek N Ahya; Gregory Tino; Alberto Pochettino; Christina Gaughan; Ejigayehu DeMissie; Stephen E Kimmel
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

6.  Outcome of lung transplanted patients with primary graft dysfunction.

Authors:  Christopher M Burton; Martin Iversen; Nils Milman; Mikhail Zemtsovski; Jørn Carlsen; Daniel Steinbrüchel; Jann Mortensen; Claus B Andersen
Journal:  Eur J Cardiothorac Surg       Date:  2006-11-28       Impact factor: 4.191

7.  Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.

Authors:  Vasilis Kosmoliaptsis; J Andrew Bradley; Linda D Sharples; Afzal Chaudhry; Timothy Key; Reyna S Goodman; Craig J Taylor
Journal:  Transplantation       Date:  2008-06-27       Impact factor: 4.939

8.  Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.

Authors:  Vasilis Kosmoliaptsis; Afzal N Chaudhry; Linda D Sharples; David J Halsall; Timothy R Dafforn; J Andrew Bradley; Craig J Taylor
Journal:  Transplantation       Date:  2009-09-27       Impact factor: 4.939

9.  HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.

Authors:  D C Walton; S J Hiho; L S Cantwell; M B Diviney; S T Wright; G I Snell; M A Paraskeva; G P Westall
Journal:  Am J Transplant       Date:  2016-04-21       Impact factor: 8.086

10.  Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response.

Authors:  Donna P Lucas; Mary S Leffell; Andrea A Zachary
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.